Literature DB >> 17364996

Thromboembolism in childhood nephrotic syndrome: a rare but serious complication.

Marco Zaffanello1, Massimo Franchini.   

Abstract

The main clinical features of nephrotic syndrome (NS) are heavy proteinuria, hypoalbuminemia, hyperlipidemia and edema. In addition, multiple abnormalities in the coagulation pathway may be a consequence of the NS. Both arterial and venous thromboembolic complications (TEC) are relatively common and serious consequences of NS. In addition, arterial and venous thrombosis might be unexpected events during an exacerbation of NS. Embolic episodes may manifest in different regions of the body such as the brain or the lung. Hence, predisposing factors, personal and family history of TEC, thrombosis location and evolution should be always investigated in children with NS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364996     DOI: 10.1080/10245330600940048

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  13 in total

Review 1.  A novel link: in children, cow milk processing may be causative of idiopathic membranous nephropathy.

Authors:  Michael Haase; Anja Haase-Fielitz; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2011-12-20       Impact factor: 2.370

2.  Evolving presentation of leg cramps in a child with nephrotic syndrome: Answers.

Authors:  Amirtha V Chinnadurai; Olivera Marsenic
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

3.  Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome.

Authors:  C P Suresh; Abhijeet Saha; Manpreet Kaur; Ritesh Kumar; N K Dubey; Trayambak Basak; Vinay Singh Tanwar; Gaurav Bhardwaj; Shantanu Sengupta; Vineeta Vijay Batra; Ashish Datt Upadhyay
Journal:  Clin Exp Nephrol       Date:  2015-09-09       Impact factor: 2.801

Review 4.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.

Authors:  Agnes Trautmann; Olivia Boyer; Elisabeth Hodson; Arvind Bagga; Debbie S Gipson; Susan Samuel; Jack Wetzels; Khalid Alhasan; Sushmita Banerjee; Rajendra Bhimma; Melvin Bonilla-Felix; Francisco Cano; Martin Christian; Deirdre Hahn; Hee Gyung Kang; Koichi Nakanishi; Hesham Safouh; Howard Trachtman; Hong Xu; Wendy Cook; Marina Vivarelli; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2022-10-21       Impact factor: 3.651

5.  Pulmonary thrombosis as the first manifestation of systemic lupus erythematosus in a 14-year-old boy.

Authors:  Annie Harroche; Natascha Remus; Solenn Gaubicher; Olivier Dunand; Magali Colombat; Christophe Delacourt; Fouad Madhi
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

6.  Chylopericardial tamponade secondary to superior vena cava thrombosis in a child with nephrotic syndrome.

Authors:  Deepti Suri; Neeraj Gupta; Chandrashekara Morigeri; Akshay Saxena; Rohit Manoj
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

7.  Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?

Authors:  Marco Zaffanello; Milena Brugnara; Vassilios Fanos; Massimo Franchini
Journal:  Int Urol Nephrol       Date:  2008-08-12       Impact factor: 2.370

8.  Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study.

Authors:  Bryce A Kerlin; Neal B Blatt; Beng Fuh; Shuang Zhao; Amy Lehman; Carol Blanchong; John D Mahan; William E Smoyer
Journal:  J Pediatr       Date:  2009-04-24       Impact factor: 4.406

9.  Clinicopathological features and prognosis of Chinese children with idiopathic nephrotic syndrome between different age groups.

Authors:  Jei-Wen Chang; Hsin-Lin Tsai; Hsin-Hui Wang; Ling-Yu Yang
Journal:  Eur J Pediatr       Date:  2008-12-20       Impact factor: 3.183

Review 10.  Venous thromboembolism in pediatric nephrotic syndrome.

Authors:  Bryce A Kerlin; Kellie Haworth; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-06-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.